Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma
Main Authors: | Lei Liang, Li-Yang Sun, Yong-Kang Diao, Tian Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-03-01
|
Series: | Liver Cancer |
Online Access: | https://www.karger.com/Article/FullText/506353 |
Similar Items
-
Reply to the Letter to the Editor: “Comparison of the Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma”
by: Clemens Schotten, et al.
Published: (2020-04-01) -
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
by: Lee VHF, et al.
Published: (2015-11-01) -
History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
by: Aman Saini, et al.
Published: (2019-01-01) -
Experience of Yttrium-90 radioembolization in patients with hepatocellular carcinoma
by: B. Zapote Hernández, et al.
Published: (2020-09-01) -
Tuning Your RADIOembolization| Imaging-guidance of Yttrium-90 Radioembolization
by: Gordon, Andrew Christian
Published: (2016)